Laboratorios Farmaceuticos Rovi, S.A. Share Price
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Market Closed -
BME
09:05:01 12/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 57.80 EUR | -0.94% |
|
-1.45% | -8.98% |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 295.61Cr 341.19Cr 276.97Cr 252.62Cr 474.94Cr 33TCr 482.24Cr 3.26TCr 1.27TCr 16TCr 1.28TCr 1.25TCr 54TCr | P/E 2026 * |
20.7x | P/E 2027 * | 17.1x |
|---|---|---|---|---|---|
| Enterprise Value | 293.99Cr 339.32Cr 275.45Cr 251.24Cr 472.33Cr 32TCr 479.59Cr 3.24TCr 1.27TCr 16TCr 1.27TCr 1.25TCr 54TCr | EV / Sales 2026 * |
3.81x | EV / Sales 2027 * | 3.23x |
| Free-Float |
31.63% | Yield 2026 * |
1.67% | Yield 2027 * | 2.02% |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | -0.94% | ||
| 1 week | -1.45% | ||
| Current month | -1.28% | ||
| 1 month | +3.21% | ||
| 3 months | -5.40% | ||
| 6 months | -25.37% | ||
| Current year | -8.98% |
| 1 week | 57.55 |  | 59.1 |
| 1 month | 53.1 | | 60.25 |
| Current year | 53.1 | | 86.7 |
| 1 year | 53.1 | | 86.7 |
| 3 years | 45.52 | | 94.8 |
| 5 years | 35.2 | | 94.8 |
| 10 years | 10.8 | | 94.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 27/07/2007 | |
| Director of Finance/CFO | - | 01/01/2001 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 17/07/2021 | |
| Director/Board Member | - | 27/07/2007 | |
| Director/Board Member | - | 27/07/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23/06/23 | Buy | Director | 1,000 | 0.0019% | ||
| 13/04/22 | Norbel Inversiones SL
| Sell | Company | 5,60,690 | 1.0000% | |
| 15/03/22 | Norbel Inversiones SL
| Sell | Company | 28,03,448 | 5.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.94% | -1.45% | +6.84% | +21.84% | 344.36Cr | |
| +0.43% | +4.31% | +90.84% | +130.99% | 1,08300Cr | |
| +0.41% | +1.27% | +50.98% | +50.05% | 63TCr | |
| -0.53% | +1.04% | +25.23% | +63.46% | 44TCr | |
| -0.92% | +0.22% | +48.34% | +37.85% | 36TCr | |
| -1.32% | -0.21% | +29.07% | +36.81% | 29TCr | |
| -1.20% | -2.78% | +5.56% | +6.09% | 25TCr | |
| +0.45% | +2.05% | +46.04% | +58.54% | 22TCr | |
| -2.51% | +1.77% | -6.55% | -51.74% | 21TCr | |
| +0.07% | +3.12% | +13.21% | +69.84% | 17TCr | |
| Average | -0.61% | +1.22% | +30.95% | +42.37% | 36.63TCr | |
| Weighted average by Cap. | -0.26% | +2.19% | +49.18% | +65.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 77Cr 89Cr 72Cr 66Cr 123.98Cr 8.5TCr 125.89Cr 850.38Cr 332.41Cr 4.25TCr 334.41Cr 327.15Cr 14TCr | 89Cr 102.82Cr 83Cr 76Cr 143.12Cr 9.81TCr 145.32Cr 981.64Cr 383.72Cr 4.91TCr 386.03Cr 377.64Cr 16TCr |
| Net income | 13Cr 15Cr 12Cr 11Cr 21Cr 1.42TCr 21Cr 141.65Cr 55Cr 708.54Cr 56Cr 54Cr 2.36TCr | 17Cr 20Cr 16Cr 15Cr 28Cr 1.91TCr 28Cr 191.62Cr 75Cr 958.49Cr 75Cr 74Cr 3.2TCr |
| Net Debt | -1.62Cr -1.87Cr -1.52Cr -1.39Cr -2.6Cr -178.49Cr -2.65Cr -18Cr -6.98Cr -89Cr -7.03Cr -6.87Cr -298.01Cr | -8.15Cr -9.41Cr -7.64Cr -6.97Cr -13Cr -897.28Cr -13Cr -90Cr -35Cr -449.28Cr -35Cr -35Cr -1.5TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | €57.80 | -0.94% | 1,00,384 |
| 11/26/11 | €58.35 | -0.60% | 64,274 |
| 10/26/10 | €58.70 | +0.60% | 75,610 |
| 07/26/07 | €58.35 | -0.43% | 66,635 |
| 06/26/06 | €58.60 | -0.09% | 99,390 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
